ArticleiScience2026
TLR7-mediated inflammation drives PD-L1 upregulation and T cell exhaustion during influenza A virus infection.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
T cell dysfunction driven by dysregulated programmed cell death-1 (PD-1)/PD-ligand (PD-L) immune checkpoint signaling is associated with severe influenza A virus (IAV) infection. While this pathway limits immunopathology, it can suppress antiviral immunity and promote T cell exhaustion. We investigated the role of toll-like receptor 7 (TLR7), a viral RNA sensor, in regulating PD-1/PD-L-mediated T cell responses during IAV infection. Using wild-type and TLR7-deficient mice, we show that TLR7 activation enhances early antiviral T cell responses but subsequently increases PD-L1/PD-L2 expression, promoting T cell exhaustion at later stages of infection. This was associated with higher lung viral loads and increased expression of exhaustion-related genes. Mechanistically, TLR7 regulated PD-L1 expression indirectly via cytokine signaling, rather than directly affecting PD-1 expression. These findings identify TLR7 as a key upstream modulator of immune checkpoint signaling during IAV infection and suggest that targeting TLR7, alone or with checkpoint inhibitors, may boost antiviral immunity and reduce T cell exhaustion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.